EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advancement of novel marine fungi derived secondary metabolite fibrinolytic compound FGFC in biomedical applications: a review

Lakshmi Jeevithan, Xiaozhen Diao, Jiudong Hu, Jeevithan Elango, Wenhui Wu, Jose Eduardo Mate Sanchez de Val, Saravanan Rajendran, Thanigaivel Sundaram, Suresh Kumar Rajamani Sekar

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1422648 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Lakshmi Jeevithan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Marine Biopharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China. Hauptthemen laut MEDLINE: Stachybotrys, Aquatic Organisms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For several decades, products derived from marine natural sources (PMN) have been widely identified for several therapeutic applications due to their rich sources of bioactive sub-stances, unique chemical diversity, biocompatibility and excellent biological activity. For the past 15 years, our research team explored several PMNs, especially fungi fibrinolytic compounds (FGFCs). FGFC is an isoindolone alkaloid derived from marine fungi, also known as staplabin analogs or Stachybotrys microspora triprenyl phenol (SMTP). For instance, our previous studies explored different types of FGFCs such as FGFC 1, 2, 3 and 4 from the marine fungi Stachybotrys longispora FG216 derived metabolites. The derivatives of FGFC are potentially employed in several disease treatments, mainly for stroke, cancer, ischemia, acute kidney injury, inflammation, cerebral infarction, thrombolysis and hemorrhagic activities, etc. Due to the increasing use of FGFCs in pharmaceutical and biomedical applications, it is important to understand the fundamental signaling concept of FGFCs. Hence, for the first time, this review collectively summarizes the background, types, mode of action and biological applications of FGFCs and their current endeavors for future therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StachybotrysAquatic OrganismsHumansFibrinolytic AgentsAnimalsSecondary MetabolismAlkaloidsBiological ProductsFungi

Stichwörter der Autor:innen

antithrombotic activitiesbiomedical applicationsfungi fibrinolytic compoundsmarine metabolitessignaling mechanism

Substanzen

Fibrinolytic AgentsAlkaloidsBiological Products

Autor:innen und Institutionen

  • Department of Marine Biopharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Department of Biomaterials Engineering, Faculty of Health Sciences, UCAM-Universidad Catolica San-Antonio de Murcia, Murcia, Spain.
  • Shanghai Sixth People's Hospital, affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Center of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
  • Instituto de Alta Investigacion, Universidad de Tarapacá, Arica, Chile.
  • Department of Biotechnology, Faculty of Science & Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.

Zitieren

APA

Jeevithan, L., Diao, X., Hu, J., Elango, J., Wu, W., Mate Sanchez de Val, J. E., Rajendran, S., Sundaram, T., & Rajamani Sekar, S. K. (2024). Recent advancement of novel marine fungi derived secondary metabolite fibrinolytic compound FGFC in biomedical applications: a review. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1422648

Vancouver

Jeevithan L, Diao X, Hu J, Elango J, Wu W, Mate Sanchez de Val JE, et al. Recent advancement of novel marine fungi derived secondary metabolite fibrinolytic compound FGFC in biomedical applications: a review. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1422648

BibTeX
@article{Jeevithan2024,
  author = {Jeevithan, Lakshmi and Diao, Xiaozhen and Hu, Jiudong and Elango, Jeevithan and Wu, Wenhui and Mate Sanchez de Val, Jose Eduardo and Rajendran, Saravanan and Sundaram, Thanigaivel and Rajamani Sekar, Suresh Kumar},
  title = {Recent advancement of novel marine fungi derived secondary metabolite fibrinolytic compound FGFC in biomedical applications: a review},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1422648}
}
Kostenlos starten →